Diagnosing sarcopenia: Functional perspectives and a new algorithm from the ISarcoPRM
Open accessThe DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Sarcopenia is an important public health problem, characterized by age-related loss of muscle mass and muscle function. It is a precursor of physical frailty, mobility limitation, and premature death. Muscle loss is mainly due to the loss of type II muscle fibres, and progressive loss of motor neurones is thought to be the primary underlying factor. Anterior thigh muscles undergo atrophy earlier, and the loss of anterior thigh muscle function may therefore be an antecedent finding. The aim of this review is to provide an in-depth (and holistic) neuromusculoskeletal approach to sarcopenia. In addition, under the umbrella of the International Society of Physical and Rehabilitation Medicine (ISPRM), a novel diagnostic algorithm is proposed, developed with the consensus of experts in the special interest group on sarcopenia (ISarcoPRM). The advantages of this algorithm over the others are: special caution concerning disorders related to the renin-angiotensin system at the case finding stage; emphasis on anterior thigh muscle mass and function loss; incorporation of ultrasound for the first time to measure the anterior thigh muscle; and addition of a chair stand test as a power/performance test to assess anterior thigh muscle function. Refining and testing the algorithm remains a priority for future research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Sarcopenia: European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Baeyens, J. P., Bauer, J. M., Boirie, Y., Cederholm, T., Landi, F., Martin, F. C., Michel, J.-P., Rolland, Y., Schneider, S. M., et al. (2010) · Age and Ageing · doi:10.1093/ageing/afq034 · Cited by 11,601
Guralnik, J. M., Simonsick, E. M., Ferrucci, L., Glynn, R. J., Berkman, L. F., Blazer, D. G., Scherr, P. A., & Wallace, R. B. (1994) · Journal of Gerontology · doi:10.1093/geronj/49.2.m85 · Cited by 9,792
Asian Working Group for Sarcopenia: 2019 Consensus Update on Sarcopenia Diagnosis and Treatment
Chen, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Chou, M.-Y., Iijima, K., Jang, H. C., Kang, L., Kim, M., Kim, S., et al. (2020) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2019.12.012 · Cited by 7,070 · cited 3×
“A variety of screening tests are proposed for sarcopenia, which is diagnosed according to ASM measurements (11, 12, 100, 101).”
BackgroundInfluentialSelf-citationGait speed and survival in older adults.
Studenski, S. (2011) · JAMA · doi:10.1001/jama.2010.1923 · Cited by 4,558 · cited 1×
“6 m/s increases the likelihood of poor health and function (127).”
BackgroundSarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Bahyah, K. S., Chou, M.-Y., Chen, L.-Y., Hsu, P.-S., Krairit, O., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.025 · Cited by 4,051 · cited 3×
“…walk × FNIH Mclean et al. 2014 (8) Studenski et al. 2014 (9) ASM/BMI ♂< 0.789 ♀< 0.512 Grip strength ♂< 26 kg ♀< 16 kg × Gait speed ≤ 0.8 m/s Inability to rise from a chair w/o support AWGS Chen et al. 2014 (10) ASM/Ht2 ♂< 7.0 kg/m2 ♀< 5.4 kg/m2 Grip strength ♂< 28 kg ♀< 18 kg Gait speed < 0.8…”
InfluentialEpidemiology of Sarcopenia among the Elderly in New Mexico
Baumgartner, R. N., Koehler, K. M., Gallagher, D., Romero, L., Heymsfield, S. B., Ross, R. R., Garry, P. J., & Lindeman, R. D. (1998) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a009520 · Cited by 4,004 · cited 1×
“Adjusted values of < 2 standard deviations (SDs) of the healthy young adults are currently considered in the diagnosis (20).”
BackgroundSarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afz046 · Cited by 3,803
Fielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256 · cited 1×
“…al. 2010 (5) ASM/Ht2 ♂< 7.26 kg/m2 ♀< 5.5 kg/m2 Grip strength ♂< 30 kg ♀< 20 kg Gait speed ≤ 0.8 m/s SPPB ≤ 8 Low (muscle mass + strength + performance) IWGS Fielding et al. 2011 (6) ASM/Ht2 ♂≤ 7.23 kg/m2 ♀≤ 5.67 kg/m2 × Gait speed < 1 m/s × SSCWD Morley et al. 2011 (7) ASM/Ht2 ♂≤ 7.26 kg/m2 ♀≤…”
InfluentialSkeletal muscle mass and distribution in 468 men and women aged 18–88 yr
Janssen, I., Heymsfield, S. B., Wang, Z., & Ross, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.89.1.81 · Cited by 3,087
Guralnik, J. M., Ferrucci, L., Pieper, C. F., Leveille, S. G., Markides, K. S., Ostir, G. V., Studenski, S., Berkman, L. F., & Wallace, R. B. (2000) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/55.4.m221 · Cited by 2,898
Studenski, S. A., Peters, K. W., Alley, D. E., Cawthon, P. M., McLean, R. R., Harris, T. B., Ferrucci, L., Guralnik, J. M., Fragala, M. S., Kenny, A. M., et al. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu010 · Cited by 2,545 · cited 3×
“8m/s and/or inability to rise from a chair without support (9).”
BackgroundInfluentialLauretani, F., Russo, C. R., Bandinelli, S., Bartali, B., Cavazzini, C., Di Iorio, A., Corsi, A. M., Rantanen, T., Guralnik, J. M., & Ferrucci, L. (2003) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00246.2003 · Cited by 1,946
Sarcopenia: Aging-Related Loss of Muscle Mass and Function
Larsson, L., Degens, H., Li, M., Salviati, L., Lee, Y. I., Thompson, W., Kirkland, J. L., & Sandri, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00061.2017 · Cited by 1,797
Muscaritoli, M., Anker, S. D., Argilés, J., Aversa, Z., Bauer, J. M., Biolo, G., Boirie, Y., Bosaeus, I., Cederholm, T., Costelli, P., et al. (2010) · Clinical Nutrition · doi:10.1016/j.clnu.2009.12.004 · Cited by 1,732 · cited 2×
“Former and ISarcoPRM diagnostic criteria for sarcopenia by different working groups (in chronological order) Study group, (reference) Diagnostic criteria Outcome (severe or mobility limited)Muscle mass Muscle strength Performance ESPEN-SIG Muscaritoli et al. 2010 (4) ASM/Wt (”
MethodInfluentialLongitudinal study of muscle strength, quality, and adipose tissue infiltration
Delmonico, M. J., Harris, T. B., Visser, M., Park, S. W., Conroy, M. B., Velasquez-Mieyer, P., Boudreau, R., Manini, T. M., Nevitt, M., Newman, A. B., et al. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.28047 · Cited by 1,446 · cited 15×
“Another 5-year longitudinal study in older adults (n = 1,678) revealed approximately 15% loss of knee extensor strength and approximately 4% loss of thigh muscle CSA, whereby the decrease in muscle strength was 2–5 times greater than the loss of muscle CSA (108).”
BackgroundInfluentialAging of skeletal muscle: a 12-yr longitudinal study
Frontera, W. R., Hughes, V. A., Fielding, R. A., Fiatarone, M. A., Evans, W. J., & Roubenoff, R. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1321 · Cited by 1,443
Self-citationSARC-F: A simple questionnaire to rapidly diagnose sarcopenia
Malmstrom, T. K., & Morley, J. E. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.018 · Cited by 1,319 · cited 2×
“measure of calf circumference and/ or a self-reported SARC-F questionnaire (Strength, Assistance with walking, Rise from a chair, Climb stairs, and Falls) has been suggested (100).”
BackgroundCesari, M., Kritchevsky, S. B., Penninx, B. W. H. J., Nicklas, B. J., Simonsick, E. M., Newman, A. B., Tylavsky, F. A., Brach, J. S., Satterfield, S., Bauer, D. C., et al. (2005) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2005.53501.x · Cited by 1,192 · cited 1×
“…s 12 Community-dwelling vs institutionalized Bischoff et al. 2003 (94) 13.5 Fall Barry et al. 2014 (95) Gait speed, m/s 1.0 Lower extremity limitation Cesari et al. 2005 (96) 1.0 Dementia Taniguchi et al. 2017 (97) 0.8 Frailty Clegg et al. 2015 (98) Short Physical Performance Battery 8 Poor…”
BackgroundInfluentialMuscle wasting in disease: molecular mechanisms and promising therapies
Cohen, S., Nathan, J. A., & Goldberg, A. L. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4467 · Cited by 1,089
Welcome to the ICD‐10 code for sarcopenia
Anker, S. D., Morley, J. E., & von Haehling, S. (2016) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12147 · Cited by 983
Skeletal Muscle Power: A Critical Determinant of Physical Functioning in Older Adults
Reid, K. F., & Fielding, R. A. (2012) · Exercise and Sport Sciences Reviews · doi:10.1097/jes.0b013e31823b5f13 · Cited by 913 · cited 1×
“Furthermore, with ageing, power declines at a faster rate than strength (121).”
BackgroundShort physical performance battery and all-cause mortality: systematic review and meta-analysis
Pavasini, R., Guralnik, J., Brown, J. C., di Bari, M., Cesari, M., Landi, F., Vaes, B., Legrand, D., Verghese, J., Wang, C., et al. (2016) · BMC Medicine · doi:10.1186/s12916-016-0763-7 · Cited by 911 · cited 1×
“…Cesari et al. 2005 (96) 1.0 Dementia Taniguchi et al. 2017 (97) 0.8 Frailty Clegg et al. 2015 (98) Short Physical Performance Battery 8 Poor physical performance Beaudart et al. 2016 (43) 9 All-cause mortality Pavasini et al. 2016 (99) aFor male vs female, respectively, or for both. s: second.”
BackgroundInfluentialSelf-citationDynapenia and aging: an update
Manini, T. M., & Clark, B. C. (2012) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glr010 · Cited by 875 · cited 2×
“cognitive impairment, polyneuropathy, movement/balance disorder, depression) should be investigated (119).”
BackgroundThe relationship between leg power and physical performance in mobility-limited older people
Md, J. F. B., Kiely, D. K., Herman, S., Leveille, S. G., Mizer, K., Frontera, W. R., & Fielding, R. A. (2002) · Journal of the American Geriatrics Society · doi:10.1046/j.1532-5415.2002.50111.x · Cited by 605
Self-citationLexell, J., Henriksson‐Larsén, K., Winblad, B., & Sjöström, M. (1983) · Muscle & Nerve · doi:10.1002/mus.880060809 · Cited by 582 · cited 1×
“By the eighth decade of life, muscle loss is approximately 30% of peak values, mainly due to loss of and atrophy of type II muscle fibres (16, 17).”
BackgroundThe role of DXA bone density scans in the diagnosis and treatment of osteoporosis
Blake, G. M., & Fogelman, I. (2007) · Postgraduate Medical Journal · doi:10.1136/pgmj.2007.057505 · Cited by 532 · cited 1×
“As hip BMD is the most reliable parameter for hip fracture risk, and as spinal BMD should be used for monitoring the treatment of osteoporosis (135), femoral neck and/or spine BMD values ≤ 2.”
BackgroundBeaudart, C., Rolland, Y., Cruz-Jentoft, A. J., Bauer, J. M., Sieber, C., Cooper, C., Al-Daghri, N., Araujo de Carvalho, I., Bautmans, I., Bernabei, R., et al. (2019) · Calcified Tissue International · doi:10.1007/s00223-019-00545-w · Cited by 528
Satellite cell content is specifically reduced in type II skeletal muscle fibers in the elderly
Verdijk, L. B., Koopman, R., Schaart, G., Meijer, K., Savelberg, H. H. C. M., & van Loon, L. J. C. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00278.2006 · Cited by 489 · cited 1×
“In addition to the altered myofibre metabolism; mitochondrial dysfunction, adipocyte infiltration, and altered satellite cell properties (reduction in their number and/or activation) are seen, especially in type II fibres (54).”
BackgroundMayhew, A. J., Amog, K., Phillips, S., Parise, G., McNicholas, P. D., de Souza, R. J., Thabane, L., & Raina, P. (2019) · Age and Ageing · doi:10.1093/ageing/afy106 · Cited by 478 · cited 1×
“According to various working groups, the prevalence of sarcopenia ranges from approximately 10% to 40% due to different methodology, diagnostic criteria, ethnicity, and selected populations (14).”
BackgroundRolland, Y., Lauwers-Cances, V., Cristini, C., van Kan, G. A., Janssen, I., Morley, J. E., & Vellas, B. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2008.26950 · Cited by 465
The reliability and validity of ultrasound to quantify muscles in older adults: A systematic review
Nijholt, W., Scafoglieri, A., Jager‐Wittenaar, H., Hobbelen, J. S. M., & van der Schans, C. P. (2017) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12210 · Cited by 459 · cited 1×
“97), especially for measuring anterior thigh muscle thickness (113, 114).”
BackgroundRelevance of Sympathetic Nervous System Activation in Obesity and Metabolic Syndrome
Thorp, A. A., & Schlaich, M. P. (2015) · Journal of Diabetes Research · doi:10.1155/2015/341583 · Cited by 425
Associations of Muscle Mass and Strength with All-Cause Mortality among US Older Adults
LI, R., XIA, J., ZHANG, X., GATHIRUA-MWANGI, W. G., GUO, J., LI, Y., MCKENZIE, S., & SONG, Y. (2018) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000001448 · Cited by 398
Clegg, A., Rogers, L., & Young, J. (2015) · Age and Ageing · doi:10.1093/ageing/afu157 · Cited by 380
Onder, G., Penninx, B. W., Balkrishnan, R., Fried, L. P., Chaves, P. H., Williamson, J., Carter, C., Bari, M. D., Guralnik, J. M., & Pahor, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08024-8 · Cited by 339 · cited 5×
“A cross-sectional study (n = 2431) has found that angiotensin-converting enzyme inhibitor (ACEI) users have larger lower limb muscle mass (57).”
BackgroundInfluentialAging of skeletal muscle fibers
Miljkovic, N., Lim, J.-Y., Miljkovic, I., & Frontera, W. R. (2015) · Annals of Rehabilitation Medicine · doi:10.5535/arm.2015.39.2.155 · Cited by 309 · cited 2×
“Although it is assumed that type I fibres are protected from atrophy by the peroxisome proliferator-activated receptor-gamma coactivator 1-α (52), it has been reported that the number of type I fibres in pectoralis minor muscle decreased after 60 years of age.”
BackgroundPutative Cut‐Points in Sarcopenia Components and Incident Adverse Health Outcomes: An SDOC Analysis
Cawthon, P. M., Manini, T., Patel, S. M., Newman, A., Travison, T., Kiel, D. P., Santanasto, A. J., Ensrud, K. E., Xue, Q., Shardell, M., et al. (2020) · Journal of the American Geriatrics Society · doi:10.1111/jgs.16517 · Cited by 231
Cruz-Jentoft, A. J., Dawson Hughes, B., Scott, D., Sanders, K. M., & Rizzoli, R. (2020) · Maturitas · doi:10.1016/j.maturitas.2019.11.007 · Cited by 144
STAR—Sonographic Thigh Adjustment Ratio: A Golden Formula for the Diagnosis of Sarcopenia
Kara, M., Kaymak, B., Ata, A. M., Özkal, Ö., Kara, Ö., Baki, A., Şengül Ayçiçek, G., Topuz, S., Karahan, S., Soylu, A. R., et al. (2020) · American Journal of Physical Medicine & Rehabilitation · doi:10.1097/phm.0000000000001439 · Cited by 137
Self-citationShin, M. J., Jeon, Y. K., & Kim, I. J. (2018) · The World Journal of Men's Health · doi:10.5534/wjmh.180001 · Cited by 134 · cited 1×
“Testosterone increases intracellular Ca2+ concentration and increases IGF-1 expression leading to muscle fibre growth (50).”
BackgroundKehoe, P. G. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-171119 · Cited by 133
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopenia
Reginster, J.-Y., Cooper, C., Rizzoli, R., Kanis, J. A., Appelboom, G., Bautmans, I., Bischoff-Ferrari, H. A., Boers, M., Brandi, M. L., Bruyère, O., et al. (2016) · Aging Clinical and Experimental Research · doi:10.1007/s40520-015-0517-y · Cited by 112
Hausberg, M., Mark, A. L., Hoffman, R. P., Sinkey, C. A., & Anderson, E. A. (1995) · Journal of Hypertension · doi:10.1097/00004872-199509000-00012 · Cited by 90
Hypertension and lower walking speed in the elderly: the three-City study
Dumurgier, J., Elbaz, A., Dufouil, C., Tavernier, B., & Tzourio, C. (2010) · Journal of Hypertension · doi:10.1097/hjh.0b013e328338bbec · Cited by 90
Comparisons of three different methods for defining sarcopenia: an aspect of cardiometabolic risk
Kim, T. N., Park, M. S., Lee, E. J., Chung, H. S., Yoo, H. J., Kang, H. J., Song, W., Baik, S. H., & Choi, K. M. (2017) · Scientific Reports · doi:10.1038/s41598-017-06831-7 · Cited by 86
Ábrigo, J., Simon, F., Cabrera, D., & Cabello-Verrugio, C. (2016) · Cellular Physiology and Biochemistry · doi:10.1159/000452522 · Cited by 35 · cited 1×
“On the other hand, in the non-classical pathway, Ang (1–7) acts as an antagonist to Ang II and exerts an antifibrotic effect (55, 60).”
Background
Metadata
- Authors
- Kara, M., Kaymak, B., Frontera, W., Ata, A., Ricci, V, Ekiz, T., Chang, K., Han, D., Michail, X., Quittan, M., Lim, J., Bean, J., Franchignoni, F., & sarcopenia, L.
- Venue
- Journal of Rehabilitation Medicine
- Published
- 2021
- Volume
- 53
- Issue
- 6
- Pages
- jrm00209
- ISSN
- 1650-1977 (ISSN-L)
- 1651-2081
- OpenAlex
- W3171868165
- Cited by
- 183
- References
- 47
- FWCI
- 18.28
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.